Ionis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.69), $0.37 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $268 million versus the consensus estimate of $190.06 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.